OPEN MARKET SALE AGREEMENTSMOpen Market Sale • March 5th, 2024 • Praxis Precision Medicines, Inc. • Pharmaceutical preparations • New York
Praxis Precision Medicines, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), having an aggregate offering price of up to $150 million on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • May 24th, 2022 • Icahn Enterprises L.P. • Motor vehicle parts & accessories • New York
Icahn Enterprises L.P., a Delaware limited partnership (the “Company”), proposes to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), the Company’s depositary units representing limited partner interests (the “Depositary Units”), having an aggregate offering price of up to the Maximum Program Amount subject to the terms and conditions set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • December 1st, 2023 • Trinity Capital Inc. • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • May 15th, 2023 • Janus International Group, Inc. • Metal doors, sash, frames, moldings & trim • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • May 8th, 2024 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations • New York
Avadel Pharmaceuticals plc, an Irish incorporated public limited company (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), the Company’s ordinary shares, nominal value $0.01 per share (the “Ordinary Shares”), on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • October 14th, 2020 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
AGENTS FOROpen Market Sale • September 4th, 2020
La Mer is a solid, block-built house constructed in 1965/6 with the recent additions of a purpose-built chalet, glasshouse, tool shed and an enclosed, covered swimming pool in the adjoining meadow. The property benefits from oil fired central heating and a wood burning stove and it is well insulated with double glazing throughout. The
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • October 20th, 2020 • Lithium Americas Corp. • Metal mining • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • February 1st, 2022 • Opthea LTD • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • October 11th, 2017 • Sierra Metals Inc. • Metal mining • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 26th, 2024 • Icahn Enterprises L.P. • Motor vehicle parts & accessories • New York
Icahn Enterprises L.P., a Delaware limited partnership (the “Company”), proposes to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), the Company’s depositary units representing limited partner interests (the “Depositary Units”), having an aggregate offering price of up to the Maximum Program Amount subject to the terms and conditions set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 23rd, 2024 • Trinity Capital Inc. • New York
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 6th, 2024 • AC Immune SA • Pharmaceutical preparations • New York
AC Immune SA, a company limited by shares (Aktiengesellschaft) incorporated under the laws of Switzerland, with registered seat in Ecublens (VD), Switzerland (the “Company”), proposes, subject to the conditions stated herein, to sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), the Company’s common shares, nominal value CHF 0.02 per share (the “Common Shares”), having an aggregate offering price of up to $80.0 million on the terms set forth in this agreement (this “Agreement”). Execution of this Agreement will supersede and replace the existing open market sale agreement (the “Existing Agreement”) between the Company and the Agent, dated May 5, 2021, with both parties acknowledging that the Existing Agreement has been terminated as of the date hereof.
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • June 14th, 2024 • Alvotech • Biological products, (no disgnostic substances) • New York
Alvotech, a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg (“Luxembourg”), having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, and registered with the Luxembourg Register of Commerce and Companies (R.C.S. Luxembourg) under number B258884 (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and/or sell from time to time through Jefferies LLC, as sales agent, subscriber and/or principal (the “Agent”), the Company’s ordinary shares, $0.01 nominal value (valeur nominale) per share (the “Ordinary Shares”) on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 6th, 2024 • ADC Therapeutics SA • Pharmaceutical preparations • New York
ADC Therapeutics SA, a Swiss stock corporation (société anonyme) domiciled in Epalinges, Switzerland, and organized under the laws of Switzerland (the “Company”), proposes, subject to the terms and conditions stated herein, to sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), common shares of the Company, nominal value CHF 0.08 per share (the “Common Shares”), having an aggregate offering price of up to $100,000,000 on the terms set forth in this agreement (this “Agreement”).
